PSNL (Personalis) Quality Rank


PSNL Personalis Inc PSNL
59 GF Score
Price $14.06
GF Value $2.08
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Personalis Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Personalis Quality Rank Related Terms

PSNL
59GF Score
Personalis Inc PSNL
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Personalis (PSNL) Overvalued in 2026?

Based on GuruFocus' analysis, Personalis stock appears to be overvalued. The current stock price of $14.06 is trading 576% above its estimated GF Value™ of $2.08. GuruFocus considers Personalis to be Significantly Overvalued.

Key valuation signals for PSNL:

  • Quality Rank:
  • GF Value™: $2.08 vs. price of $14.06 (576% above fair value)
  • GF Score™: 59/100 with 9 warning signs

No single metric tells the full story. See the PSNL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Personalis Business Description

Other Exchanges 04X:Germany
Address 6600 Dumbarton Circle, Fremont, CA, USA, 94555
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
59GF Score

Get the complete analysis for PSNL

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.06
Price
$2.08
GF Value